NigelSKeyMD
Hematology • Chapel Hill, NCProfessor, Medicine, University of North Carolina at Chapel Hill School of Medicine
Dr. Key is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
116 Manning Drive
CB #7036
Chapel Hill, NC 27599Phone+1 919-966-3311
Summary
- Dr. Nigel Key is a hematologist in Chapel Hill, NC and is affiliated with University of North Carolina Hospitals. He received his medical degree from University of Manchester Faculty of Medicine and has been in practice 36 years. He is experienced in thrombotic disorders, general / benign hematology, and transfusion medicine.
Education & Training
University of MinnesotaFellowship, Hematology and Medical Oncology, 1988 - 1990
University of Manchester Faculty of MedicineClass of 1981
Certifications & Licensure
NC State Medical License 2009 - 2024
MN State Medical License 1990 - 2018
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
- Rituximab to Treat Severe Hemophilia A Start of enrollment: 2006 Jun 01
- Evaluating the Presence of Blood Clots in People With Heparin-Induced Thrombocytopenia (HIT) (The HOT Study) Start of enrollment: 2008 Jan 01
- Safety and Effectiveness of Granulocyte Transfusions in Resolving Infection in People With Neutropenia (The RING Study) Start of enrollment: 2008 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- 89 citationsCoagulation abnormalities of sickle cell disease: Relationship with clinical outcomes and the effect of disease modifying therapiesDenis F. Noubouossie, Nigel S. Key, Kenneth I. Ataga
Blood Reviews. 2016-07-01 - 852 citationsVenous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline UpdateNigel S. Key, Alok A. Khorana, Nicole M. Kuderer, Kari Bohlke, Agnes Y. Lee
Journal of Clinical Oncology. 2020-02-10 - 139 citationsAssociation of sickle cell trait with chronic kidney disease and albuminuria in African Americans.Rakhi P. Naik, Vimal K. Derebail, Morgan E. Grams, Nora Franceschini, Paul L. Auer
JAMA. 2014-11-26
Press Mentions
Newsworthy from the School of Medicine, Week of July 22 – July 28July 27th, 2022- Gene Therapy Reduced Risk of Excessive Bleeding for People with Hemophilia B, Early Trial Data SuggestsJuly 22nd, 2022
- Data from Spain Yield New Insights on a Rare HemophiliaNovember 2nd, 2021
- Join now to see all
Grant Support
- Mechanisms Of Venous Thromboembolism In CancerNational Heart, Lung, And Blood Institute2008–2012
- Research Fellowships In Hematology/OncologyNational Heart, Lung, And Blood Institute2005–2011
- Rituximab For The Treatment Of Inhibitors In Congenital Hemophilia ANational Center For Research Resources2008
- PREVENT: Prevention Of Recurrent Venous ThromboembolismNational Center For Research Resources2004
- Catheter Directed Thrombolytic Therapy In Deep Vein ThrombosisNational Center For Research Resources2004
- New Therapies For HemophiliaNational Heart, Lung, And Blood Institute2000–2004
- Tissue Factor In HemophiliaNational Heart, Lung, And Blood Institute2000–2002
- PREVENT: Prevention Of Recurrent Venous ThromboembolismNational Center For Research Resources2000–2002
- Endothelial Cells In HomocystinuriaNational Center For Research Resources2000–2002
- Mechanisms Of Thrombosis In Sickle DiseaseNational Heart, Lung, And Blood Institute1995–1998
- The Role Of The Neutrophil In Inflammatory ThrombosisNational Heart, Lung, And Blood Institute1990–1991
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
